OptimizeRx Corporation (OPRX)

NCM – Real Time Price. Currency in USD

4.89

-1.45 (-22.87%)

Market open: May 13, 2026, 10:30 AM EDT

13.05.2026

OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript

12.05.2026

OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.08 per share a year ago.

12.05.2026

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

– Q1 revenue totals $19.8 million– Q1 net loss and adjusted EBITDA came in at $(0.5) million and $3.3 million, respectively– 2026 revenue guidance updated to $95-$100 million; adjusted EBITDA guidance unchanged at $21-$25 million– Paid off an incremental $2.7 million in principal from term loan during Q1– Completed debt refinancing, subsequent to end of Q1, with a $35 million traditional banking facility, resulting in expected $1.5 million in annual interest expense savings– Launched operating efficiency initiatives, subsequent to end of Q1, with expected annualized savings of $3 million, including $1 million in 2026 WALTHAM, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the three months ended March 31, 2026.

12.05.2026

OptimizeRx Expands EHR Advertising Reach With New DSP Integration

OPRX launched a programmatic EHR ad connection for DSPs, expanding point-of-care targeting and access to authenticated inventory.

11.05.2026

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

Expands life sciences marketers' reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx's trusted EHR network for the first time Expands life sciences marketers' reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx's trusted EHR network for the first time

07.05.2026

Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?

OptimizeRx nears Q1 earnings amid declining revenue forecasts, softer trends and a cautious outlook, raising questions on near-term upside.

05.05.2026

Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline

OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Videos

No Data

There is no data to display

Press releases

12.05.2026

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

11.05.2026

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

29.04.2026

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

WALTHAM, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and Governance (ESG) report for 2026.

08.04.2026

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

Microsoft Health & Life Sciences COO brings expertise in scaling healthcare platforms, commercializing new technologies, and driving operational efficiency Microsoft Health & Life Sciences COO brings expertise in scaling healthcare platforms, commercializing new technologies, and driving operational efficiency

OptimizeRx Corporation (OPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

OptimizeRx Corporation (OPRX)

OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript

OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Expands EHR Advertising Reach With New DSP Integration

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?

Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline

Videos

No Data

Press releases

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript

OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Expands EHR Advertising Reach With New DSP Integration

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?

Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline

Videos

No Data

Press releases

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

Search stocks

OptimizeRx Corporation (OPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

OptimizeRx Corporation (OPRX)

OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript

OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Expands EHR Advertising Reach With New DSP Integration

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?

Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline

Videos

No Data

Press releases

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript

OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Expands EHR Advertising Reach With New DSP Integration

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?

Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline

Videos

No Data

Press releases

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

OptimizeRx Appoints Mary Varghese Presti to Board of Directors